Welcome to TERM
Tissue Engineering and Regenerative Medicine
The Tissue Engineering and Regenerative Medicine (TERM) group is based at the Biomedical Center (BMC), Faculty of Medicine, Department of Clinical Sciences, Orthopaedics, Lund University. Our research is translational with focus on repair, regenerate and replace diseased tissues. Engineered tissues and methods developed by our group will improve the quality of life of patients and potentially alleviate the burden on the public healthcare system. Special area of interest is musculoskeletal conditions.
The TERM Lund lab has close collaboration with Skåne University Hospital and major university centers globally. The group has during the last three years received 2.5 million Euro in competitive grants.
Disclaimer: This is an external website from the Tissue engineering and Regenerative Medicine (TERM) group , working at the Lund University.
Recent Updates
01
ORS 2023 Annual meeting
Our group presented their research work in the area of tumor, fracture fixation and bone infection. Deepak Raina was also nominated for the New Investigator Recognition Award (NIRA).
02
Study published in Journal of Bone and Joint Infection
A study reporting that systemic rifampicin shows accretion to locally implanted hydroxyapatite particles in a rat abdominal muscle pouch model published in Journal of Bone and Joint Infection.
03
Yang Liu defended his Doctoral Thesis
December 2022 Yang Liu, defended his thesis “Hydroxyapatite – A trojan horse in the delivery of apatite-binding cytostatics in bone cancer” at the Faculty of Medicine, Lund University.
04
Study published in Frontiers in Bioengineering and Biotechnology
Safety study titled ‘Longitudinal in vivo bio distribution of nano and micro sized hydroxyapatite particles implanted in a bone defect’ published on Frontiers in Bioengineering and Biotechnology.
05
Article published by the Medical Faculty at Lund University
The Medical Faculty at Lund University published a news article highlighting our research work on treatment of osteosarcoma.
Link:https://www.lu.se/artikel/trojansk-hast-levererar-cytostatika-i-cancerceller
Research Areas
Bone Regeneration
A regenerative medicine approach for fragility fractures, improving implant anchorage leading to less fixation failures, re-operations
Tumor
Targeted delivery of anti-tumor drugs using bone minerals as a recruiting platform.
Selected presentations and posters
